| Schedule of Earnings Per Share, Basic and Diluted |
The following table shows the computation of basic and diluted earnings per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
| Net loss |
$ |
(84,130,722) |
|
|
$ |
(11,493,587) |
|
|
$ |
(210,705,940) |
|
|
$ |
(37,817,959) |
|
| Deemed dividends |
— |
|
|
— |
|
|
— |
|
|
86,207 |
|
| Net loss attributable to common stockholders |
$ |
(84,130,722) |
|
|
$ |
(11,493,587) |
|
|
$ |
(210,705,940) |
|
|
$ |
(37,904,166) |
|
|
|
|
|
|
|
|
|
| Basic weighted average shares outstanding |
107,406,000 |
|
|
66,176,921 |
|
|
83,611,526 |
|
|
63,566,295 |
|
| Dilutive effect of options and warrants |
— |
|
|
— |
|
|
— |
|
|
— |
|
| Dilutive effect of Convertible Note |
— |
|
|
— |
|
|
— |
|
|
— |
|
| Diluted weighted average shares outstanding |
107,406,000 |
|
|
66,176,921 |
|
|
83,611,526 |
|
|
63,566,295 |
|
|
|
|
|
|
|
|
|
| Anti-dilutive options and warrants excluded from diluted average shares outstanding |
5,948,219 |
|
|
32,917,619 |
|
|
5,948,219 |
|
|
32,917,619 |
|
|